ARCHIVES

Advocates Oppose Proposals to Market Drugs After Phase I.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Arzerra Promising For Heavily Pre-Treated CLL Patients

December 26, 2008

FDA says new tools needed to speed therapeutics development.

March 26, 2004

Also in this 8-page issue: NCI informatics project caBIG will “rapidly accelerate” cancer research, von Eschenbach says.

March 12, 2004

In Brief: Kennedy Seeing Comments On HAS Regulations; Shimkins History of Cancer Now Available

November 11, 1977

Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models

November 20, 1998

Arizona Cancer Center Convinces State To Set Lower Limits For Aflatoxin

February 23, 1979